Reply to Lai and Wei
- Su, Chia ping
- Chan, K Arnold
- Huang, Ching Tai
- Fang, Chi Tai
Taiwan Centers for Disease Control, Ministry of Health and Welfare, Taipei, Taiwan
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
Health Data Research Center, National Taiwan University, Taipei, Taiwan
Division of Infectious Diseases, Department of Internal Medicine, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
Division of Infectious Diseases, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
Correspondence: C.-T. Fang, Division of Infectious Diseases, Department of Internal Medicine, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan ([email protected]).
Potential conflicts of interest. C.-T. F. reports support for the present manuscript from Taiwan Centers for Disease Control (government-funded Neuraminidase Inhibitors Prescription Database), Taiwan National Health Insurance Agency (National Health Insurance Claims Database), and Taiwan Ministry of Health and Welfare (Data Center Service). K. A. C. reports research grants to National Taiwan University Hospital outside of the submitted work from Takeda, MSD, Amgen, and Boehringer Ingelheim; consulting fees paid to K. A. C. from Bayer, Analysis Group, and Atheneum; and writing support for a manuscript from Novartis. All other authors report no potential conflicts.
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
